Eluxadoline Catalog No.:M8654-10 in both cancer cells and

in both cancer cells and normal cells

GSK461364 is a potent inhibitor of cell proliferation causing 50% growth inhibition (GI50) below 100 nM in most of the cell lines tested with limited toxicity against human nonproliferating cells

30-tris(propan-2-yl)-1

LY364947 inhibits TGF- β -dependent luciferase production in mink lung cells (p3TP lux) and growth in mouse fibroblasts (NIH 3T3)

Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3

Eluxadoline Catalog No.:M8654-10 in both cancer cells andEluxadoline is an orally active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea predominant irritable bowel syndrome (IBS D). Eluxadoline is a and opioid receptor agonist and opioid receptor antagonist that acts locally in the enteric nervous system, possibly decreasing adverse effects on the central nervous system. This product is discontinued (DEA Schedule IV). Product information CAS Number: 864821 90 9